Inventia Healthcare Recalled Chlorthalidone Tablets
The FDA initiated a recall of 25 mg blood pressure medication due to concerns about how the tablets dissolve.
Updated on Sept. 22, 2026 in Heart Disease
Live Poll
Do you feel confident that the generic prescription medications you receive are consistently safe and effective?
Inventia Healthcare Limited recalled 13,567 bottles of its 25 mg chlorthalidone tablets on September 3, 2026. This action follows a previous recall of 11,460 bottles of the medication that occurred earlier in June 2026.
Why it matters
The tablets failed to meet dissolution specifications, which could potentially impact how the medication is absorbed by the body. This recall affects patients managing high blood pressure, a condition that currently impacts 120 million U.S. adults.
The FDA classified this as a Class II recall, which signifies that the product's failure to meet dissolution specifications may result in temporary or reversible health consequences. This follows a previous recall of the same medication in June 2026.
The players
Inventia Healthcare Limited
An India-based pharmaceutical manufacturer that produces various medications and active pharmaceutical ingredients.
FDA
The federal agency responsible for protecting public health by ensuring the safety and efficacy of human drugs.
The details
Dissolution specifications refer to the rate at which a solid medication dissolves in a liquid medium to release the active drug. When tablets fail these tests, it suggests the medication may not release the intended dose at the proper speed within the gastrointestinal tract. Patients should identify their specific lot number and check it against the FDA Enforcement Report to determine if their prescription is affected.
Timeline
A previous recall of chlorthalidone occurred in June 2026.
Inventia Healthcare initiated the second recall on September 3, 2026.
Health Landscape
This recall operates within the established regulatory framework of the FDA's Class II recall classification system. It reflects ongoing quality control standards for generic antihypertensive medications in the United States.
If you are currently taking 25 mg chlorthalidone, check your bottle against the official FDA Enforcement Report to verify your lot number. Please reach out to your pharmacist or physician to discuss the status of your medication and determine if a replacement is necessary.
The takeaway
Product recalls are a standard safety mechanism to ensure medications meet required chemical standards. If you have concerns about your blood pressure medication, always have a conversation with your pharmacist or physician before making any changes to your treatment regimen.
Further reading
For more on managing cardiovascular health, visit Heart Disease.
Live Poll
Do you feel confident that the generic prescription medications you receive are consistently safe and effective?
